Halsey Associates’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-27,190
Closed -$5.18M 111
2018
Q3
$5.18M Sell
27,190
-22
-0.1% -$4.04K 0.92% 36
2018
Q2
$4.54M Sell
27,212
-2,431
-8% -$390K 0.88% 35
2018
Q1
$4.99M Buy
29,643
+27,887
+1,588% +$4.68M 0.88% 38
2017
Q4
$287K Sell
1,756
-8,941
-84% -$1.6M 0.05% 93
2017
Q3
$2.19M Buy
10,697
+206
+2% +$47.9K 0.43% 46
2017
Q2
$2.55M Buy
10,491
+3,543
+51% +$833K 0.52% 41
2017
Q1
$1.66M Buy
+6,948
New +$1.62M 0.35% 47

Other funds holding AGN

Halsey Associates's AGN Position: Q4 2018 in Review

Halsey Associates sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 27,190 shares — an estimated $5.18M sold.

Halsey Associates first reported a position in AGN in Q1 2017 and held it in 7 quarters. The position peaked at $5.18M in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Halsey Associates reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Halsey Associates sold 27,190 Allergan plc shares in Q4 2018, an estimated $5.18M.
  • Halsey Associates first reported a position in Allergan plc in Q1 2017 and held it in 7 quarters.
  • Halsey Associates's Allergan plc position peaked at $5.18M in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Halsey Associates's 13F filing for Q4 2018, filed 15 Feb 2019.